[JAZZ] Jazz Pharmaceuticals plc

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 8.62 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 110.4 Change: 3.79 (3.56%)
Ext. hours: Change: 0 (0%)

chart JAZZ

Refresh chart

Strongest Trends Summary For JAZZ

JAZZ is in the medium-term down -24% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. Its products comprise Xyrem for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment and prevention of VOD, a potentially life-threatening complication of HSCT; Prialt for the management of severe chronic pain; and FazaClo LD and FazaClo HD tablets for the treatment-resistant schizophrenia, as well as Versacloz for treatment-resistant schizophrenia. The company also develops JZP-110, an investigational compound, which is in clinical development for the treatment of EDS in patients with narcolepsy; and JZP-386, a deuterium-modified analog of sodium oxybate products that is under pre-clinical research and development and is intended for the treatment of narcolepsy patients.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding60.49 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.21% Sales Growth - Q/Q-5.74% P/E
P/E To EPS Growth P/S6.97 P/BV6.6 Price/Cash Per Share
Price/Free Cash Flow23.32 ROA6.85% ROE16.99% ROI8.26%
Current Ratio5 Quick Ratio4.86 Long Term Debt/Equity1.51 Debt Ratio0.17
Gross Margin90.71% Operating Margin30.68% Net Profit Margin17.95% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-3.26 M Cash From Operating Activities18.29 M Gross Profit281.01 M
Net Profit96.56 M Operating Profit116.76 M Total Assets3.24 B Total Current Assets1.1 B
Total Current Liabilities220.58 M Total Debt1.33 B Total Liabilities1.93 B Total Revenue309.3 M
Technical Data
High 52 week183.18 Low 52 week115.94 Last close131.05 Last change0.05%
RSI30 Average true range3.79 Beta1.33 Volume518.32 K
Simple moving average 20 days-3.6% Simple moving average 50 days-2.76% Simple moving average 200 days-11.5%
Performance Data
Performance Week4.03% Performance Month-6.49% Performance Quart5.06% Performance Half-13.91%
Performance Year-14.95% Performance Year-to-date5.72% Volatility daily1.98% Volatility weekly4.42%
Volatility monthly9.07% Volatility yearly31.41% Relative Volume302.29% Average Volume648.84 K
New High New Low

News

2019-06-18 09:45:01 | Jazz's JAZZ New Sleep Drug Sunosi Gets Schedule IV Status

2019-06-18 08:02:10 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-17 08:00:00 | Jazz Pharmaceuticals Receives Schedule IV Designation from DEA for Sunosiā„¢ solriamfetol

2019-06-14 09:10:01 | Should Value Investors Buy Jazz Pharmaceuticals JAZZ Stock?

2019-06-13 08:01:55 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-11 08:02:20 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-10 08:02:05 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-08 08:02:53 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-06 12:23:46 | Should You Worry About Jazz Pharmaceuticals plc's NASDAQ:JAZZ CEO Pay?

2019-06-06 09:31:01 | Why Is Jazz JAZZ Down 7.3% Since Last Earnings Report?

2019-06-06 08:02:59 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-05 09:30:01 | JAZZ or ZTS: Which Is the Better Value Stock Right Now?

2019-06-04 08:02:06 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-06-03 08:00:00 | Jazz Pharmaceuticals Appoints Dr. Robert Iannone as Executive Vice President, Research and Development

2019-05-31 07:34:40 | The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering

2019-05-28 09:36:01 | Zacks.com featured highlights include: Gilead, Jazz, Amdocs, Arch Capital and Legg Mason

2019-05-27 08:45:12 | Is Jazz JAZZ a Solid Growth Stock? 3 Reasons to Think " Yes "

2019-05-24 09:16:01 | 5 Best PEG Stocks Suitable for GARP Investors

2019-05-21 09:02:45 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-05-20 09:30:01 | JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now?

2019-05-17 09:10:01 | Is Jazz Pharmaceuticals JAZZ Stock Undervalued Right Now?

2019-05-16 16:30:00 | Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress

2019-05-10 09:55:01 | 3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates

2019-05-10 08:45:12 | 3 Reasons Why Growth Investors Shouldn't Overlook Jazz JAZZ

2019-05-09 08:00:00 | Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019

2019-05-08 08:01:12 | Jazz Pharma JAZZ Q1 Earnings and Sales Beat Estimates

2019-05-08 06:00:00 | Jazz Pharmaceuticals Hits All the Right Notes in Q1

2019-05-08 03:57:26 | Edited Transcript of JAZZ earnings conference call or presentation 7-May-19 8:30pm GMT

2019-05-08 01:24:19 | Jazz Pharmaceuticals JAZZ Q1 2019 Earnings Call Transcript

2019-05-07 19:35:11 | Jazz Pharmaceuticals JAZZ Beats Q1 Earnings and Revenue Estimates

2019-05-07 18:29:56 | Jazz: 1Q Earnings Snapshot

2019-05-07 16:05:00 | Jazz Pharmaceuticals Announces First Quarter 2019 Financial Results

2019-05-07 13:07:13 | 5 Stocks With Low Price-Earnings Ratios

2019-05-07 08:04:36 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-05-06 16:05:00 | Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

2019-05-06 13:40:05 | What Should Investors Know About Jazz Pharmaceuticals plc's NASDAQ:JAZZ Earnings Outlook?

2019-05-02 09:30:01 | JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now?

2019-04-30 10:32:02 | Jazz Pharmaceuticals JAZZ Reports Next Week: Wall Street Expects Earnings Growth

2019-04-30 08:02:20 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-04-29 09:15:01 | Zoetis ZTS Hits Fresh High: Is There Still Room to Run?

2019-04-23 16:05:00 | Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019

2019-04-18 20:05:05 | Are Hedge Funds Right About Jazz Pharmaceuticals?

2019-04-16 09:30:01 | JAZZ vs. ZTS: Which Stock Is the Better Value Option?

2019-04-16 08:47:07 | Should We Be Cautious About Jazz Pharmaceuticals plc's NASDAQ:JAZZ ROE Of 16%?

2019-04-16 08:45:12 | 3 Reasons Why Jazz JAZZ Is a Great Growth Stock

2019-04-11 09:46:01 | Concert Pharma Initiates Early-Stage Schizophrenia Study

2019-04-09 10:46:50 | See what the IHS Markit Score report has to say about Jazz Pharmaceuticals PLC.

2019-04-04 18:20:12 | Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe

2019-04-04 18:16:58 | Drugmakers Jazz, Alexion, Lundbeck to pay $123 mln to resolve U.S. charity kickback probe

2019-04-04 10:34:00 | Jazz Pharma, Alexion and Lundbeck to pay $122.6 million to resolve kickback allegations